El Saadany, T., J. Lupatsch, M. Mark, M. Barbier, T. Mehra, M. Schwenkglenks, and R. von Moos. “A Cost-Effectiveness Analysis of Sotorasib As Second-Line Treatment for Patients With KRAS-G12C-Mutated Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Switzerland”. Swiss Medical Weekly, vol. 155, no. 1, Jan. 2025, p. 3777, doi:10.57187/s.3777.